Personalized cancer treatment
delivered with AI
EIC Accelerator Funding
DoMore Diagnostics has been selected to receive European Innovation Council (EIC) funding, combining grants and equity awarded up to €10 million in financing. The EIC Accelerator offers start-ups and SMEs grants of up to €2.5 million combined with equity investments through the EIC Fund ranging from €0.5 to €15 million or more. In addition to financial support, all projects benefit from a range of Business Acceleration Services that provide access to leading expertise, corporates, investors and ecosystem actors.
Read more here.
Latest News
Solid scientific foundation
DoMore Diagnostics was established to meet the need for novel methods in precision medicine to personalize treatment for cancer patients and is based on prominent research from leading institutions like Oslo University Hospital, Oxford University and University College of London. The research project was selected as a Lighthouse project by the Norwegian Research Council to develop new diagnostic methods for cancer based on artificial intelligence. The project was led by the late Prof. Håvard Danielsen with an aim to utilize new AI technology in digital pathology to reduce over- and undertreatment in cancer. The lack of objective and precise methods for cancer prognosis is a limiting step to optimize treatment of cancer patients worldwide.
Artificial intelligence in cancer diagnostics
Artificial intelligence is undergoing a breakthrough in medicine, and several trends support new solutions to predict outcomes in cancer patients. Digital pathology and new AI algorithms are on their way into clinical practice and will play a significant role in the future of medicine. Watch Professor Marco Novelli at University College of London talk about the potential of artificial intelligence in pathology.
